Dr Abubakar Sha'Aban

2026

• Khadari, M. Z. et al., 2026. Health literacy and health-related quality of life across late pregnancy in women with and without gestational hypertension: a longitudinal study in Penang, Malaysia. Women 6 (3) 54. (10.3390/women6030054)
• Mohammed, M. et al., 2026. Clinical guideline-guided prognostic models of functional disability after acute ischemic stroke: a retrospective cohort study. BMC Neurology 26 301. (10.1186/s12883-025-04432-w)
• Kang, J. et al., 2026. Global burden of amphetamine, cannabis, cocaine and opioid use in 204 countries, 1990–2023: a Global Burden of Disease Study. Nature Medicine 32 , pp.527-544. (10.1038/s41591-025-04137-0)
• Oh, J. et al., 2026. Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990–2023: a Global Burden of Disease study. Nature Medicine 32 , pp.197-223. (10.1038/s41591-025-04077-9)

2025

• Mazzaschi, F. et al. 2025. What members of the public think NHS dental services should include: qualitative study. IJQHC Communications 5 (2) lyaf015. (10.1093/ijcoms/lyaf015)
• Stark, B. A. et al., 2025. Global, regional, and national burden of cardiovascular diseases and risk factors in 204 countries and territories, 1990-2023. Journal of the American College of Cardiology 86 (22), pp.2167-2243. (10.1016/j.jacc.2025.08.015)
• Kiseleva, M. et al. 2025. Learning Disability Liaison services in acute care: a rapid review of effectiveness, barriers, and facilitators [Preprint]. null (10.31234/osf.io/j5pqh_v1)
• Sha’aban, A. et al. 2025. Patients’ views on a subsidy card model for gluten-free food access: a qualitative study. BMC Health Services Research 25 (1) 1418. (10.1186/s12913-025-13582-z)
• Naghavi, M. et al., 2025. Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023. The Lancet 406 (10513), pp.1811-1872. (10.1016/S0140-6736(25)01917-8)
• Schumacher, A. E. et al., 2025. Global age-sex-specific all-cause mortality and life expectancy estimates for 204 countries and territories and 660 subnational locations, 1950–2023: a demographic analysis for the Global Burden of Disease Study 2023. The Lancet 406 , pp.1731-1810. (10.1016/s0140-6736(25)01330-3)
• Sha'aban, A. et al. 2025. Coproducing data-driven organisational safety with patients: development and cognitive testing of a multi-setting patient-reported safety concern tool. International Journal for Quality in Health Care 37 (3) mzaf056. (10.1093/intqhc/mzaf056)
• Sha'aban, A. et al. 2025. Public awareness of care pathways and available skill mix in NHS dental teams: A qualitative study. British Dental Journal 239 , pp.39-45. (10.1038/s41415-025-8491-z)
• Mohammed, M. et al., 2025. Direct medical cost of first-ever acute ischemic stroke in Malaysia: a retrospective cohort study. Scientific Reports 15 (1) 22571. (10.1038/s41598-025-07026-1)
• Mohammed, M. et al., 2025. Prognostic models of mortality following first‐ever acute ischemic stroke: A population‐based retrospective cohort study. Health Science Reports 8 (2) e70445. (10.1002/hsr2.70445)
• Zakour Khadari, M. et al., 2025. Expectant management of severe preeclampsia in advanced maternal age with multiple risk factors: A case report. Cureus: Journal of Medical Science 17 (2) e79600. (10.7759/cureus.79600)
• Maslub, M. G. M. et al., 2025. Implementing cytochrome P450 pharmacogenomics in clinical practice: A glimmer of hope or simply a mirage?. ERU Research Journal 4 (1), pp.2063-2091. (10.21608/erurj.2024.275758.1131)

2024

• Jatau, A. I. and Sha'aban, A. 2024. Health literacy in complementary and alternative medicine. In: Awaisu, A. et al., Health Literacy in Medicines Use and Pharmacy: A Definitive Guide. Elsevier (Academic Press). , pp.225-236. (10.1016/B978-0-12-824407-4.00024-6)
• Maslub, M. G. et al., 2024. CYP3A4*1B and CYP3A5*3 SNPs significantly impact the response of Egyptian candidates to high-intensity statin therapy to atorvastatin. European Journal of Medical Research 29 539. (10.1186/s40001-024-02109-7)
• Zakour Khadari, M. et al., 2024. Health-related quality of life in pregnant women with gestational hypertension: a systematic review. Cureus: Journal of Medical Science 16 (5) e61340. (10.7759/cureus.61340)
• Edwards, D. et al. 2024. A rapid review of the effectiveness of interventions to enhance equitable or overall access to mental health services by ethnic minority groups. [Online].medRxiv. (https://doi.org/10.1101/2024.05.16.24307468)Available at: https://doi.org/10.1101/2024.05.16.24307468.
• Csontos, J. et al. 2024. What works to support better access to mental health services (from primary care to inpatients) for minority groups to reduce inequalities? A rapid evidence summary. [Online].medRxiv. (https://doi.org/10.1101/2024.02.28.24303432)Available at: https://doi.org/10.1101/2024.02.28.24303432.
• Akkaif, M. A. et al., 2024. The impact of CYP2C19 genotype on the platelet reactivity index (PRI) among chronic coronary syndromes (CCS) patients undergoing percutaneous coronary intervention (PCI): Affectability of rapid genetic testing. Cardiovascular Drugs and Therapy (10.1007/s10557-024-07544-6)

2023

• Kiseleva, M. et al. 2023. A rapid review of physical health risks associated with special procedures (tattooing, body piercing, acupuncture, electrolysis). [Online].medRxiv. (10.1101/2023.12.11.23299649)Available at: https://doi.org/10.1101/2023.12.11.23299649.
• Maslub, M. G. et al., 2023. Association between CYP3A4/CYP3A5 genetic polymorphisms and treatment outcomes of atorvastatin worldwide: is there enough research on the Egyptian population?. European Journal of Medical Research 28 381. (10.1186/s40001-023-01038-1)
• Jatau, A. I. , Sha'aban, A. and Auwal, F. 2023. Challenges/barriers of deprescribing during COVID-19. In: Elbeddini, A. ed. Deprescribing and Polypharmacy in an Aging Population. Elsevier. , pp.123-137. (10.1016/B978-0-323-99138-4.00005-9)
• Mohammed, M. et al., 2023. Psychometric properties and assessment of knowledge, attitude, and practice towards ChatGPT in pharmacy practice and education: a study protocol. Journal of Racial and Ethnic Health Disparities (10.1007/s40615-023-01696-1)
• Edwards, D. et al. 2023. What is the forecasted prevalence and incidence of long-term conditions in Wales: a rapid evidence map. medRxiv (10.1101/2023.06.23.23291814)
• Bala, A. A. et al., 2023. Pre-clinical efficacy of African medicinal plants used in the treatment of snakebite envenoming: A systematic review. Toxicon: An Interdisciplinary Journal on the Toxins Derived from Animals, Plants and Microorganisms 224 , pp.1-12. 107035. (10.1016/j.toxicon.2023.107035)
• Zawiah, M. et al., 2023. Diagnosis and treatment of stroke associated pneumonia: qualitative exploration of clinicians' practice. Electronic Journal of General Medicine 20 (2) em454. (10.29333/ejgm/12849)

2022

• Akkaif, M. A. et al., 2022. The impact of SARS-CoV-2 treatment on the cardiovascular system: an updated review. Inflammopharmacology 30 (4), pp.1143-1151. (10.1007/s10787-022-01009-8)
• Sha'aban, A. et al. 2022. Prediction of low-dose aspirin-induced gastric toxicity using nuclear magnetic resonance spectroscopy-based pharmacometabolomics in rats. Molecules 27 (7) 2126. (10.3390/molecules27072126)
• Mohammed, M. et al., 2022. Assessment of COVID-19 information overload among the general public. Journal of Racial and Ethnic Health Disparities 9 (1), pp.184-192. (10.1007/s40615-020-00942-0)
• Tangiisuran, B. et al., 2022. Physicians' perceived barriers and enablers for deprescribing among older patients at public primary care clinics: a qualitative study. International Journal of Clinical Pharmacy 44 (1), pp.201-213. (10.1007/s11096-021-01336-w)
• Maslub, M. G. et al., 2022. Assessment of the latest prescribed drug-related problems. European Review for Medical and Pharmacological Sciences 26 (7), pp.2373-2387. (10.26355/eurrev_202204_28467)

2021

• Akkaif, M. A. et al., 2021. A review of the effects of ticagrelor on adenosine concentration and its clinical significance. Pharmacological Reports 73 (6), pp.1551-1564. (10.1007/s43440-021-00309-0)
• Mustapha, M. et al., 2021. Factors associated with acceptance of COVID-19 vaccine among University health sciences students in Northwest Nigeria. PLoS ONE 16 (11) e0260672. (10.1371/journal.pone.0260672)
• Akkaif, M. A. et al., 2021. Coronary heart disease (CHD) in elderly patients: which drug to choose, ticagrelor and clopidogrel? A systematic review and meta-analysis of randomized controlled trials. Journal of Cardiovascular Development and Disease 8 (10) 123. (10.3390/jcdd8100123)
• Mohammed, M. et al., 2021. Risk factors associated with mortality among patients with novel coronavirus disease (COVID-19) in Africa. Journal of Racial and Ethnic Health Disparities 8 (5), pp.1267-1272. (10.1007/s40615-020-00888-3)
• Mohammed, M. et al., 2021. Trends in output of research in clinical prediction models of stroke outcomes: A bibliometric analysis [Abstract]. Pharmacoepidemiology and Drug Safety 30 (S1), pp.433-434. (10.1002/pds.5307)
• Akkaif, M. A. et al., 2021. The role of genetic polymorphism and other factors on clopidogrel resistance (CR) in an Asian population with coronary heart disease (CHD). Molecules 26 (7) 1987. (10.3390/molecules26071987)

2019

• Wada, A. S. et al., 2019. Use of traditional medicines among pharmacists in Nigeria.. Complementary Therapies in Clinical Practice 35 , pp.53-56. (10.1016/j.ctcp.2019.01.014)

2018

• Hammad, M. A. et al., 2018. The effect of glycated hemoglobin control on diabetic foot complications.. Value in Health 21 , pp.S119-S120. (10.1016/j.jval.2018.09.713)
• Sha'aban, A. et al. 2018. Improving aspirin toxicity through precision medicine.. Value in Health 21 , pp.S93-S93. (10.1016/j.jval.2018.09.550)
• Hammad, M. A. et al., 2018. Validation of the Malay version of Mini-Addenbrooke's Cognitive Examination: a pilot study.. Value in Health 21 , pp.S7-S8. (10.1016/j.jval.2018.07.052)